SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics

By Simpkins Fiona   Czechowicz Josephine A   Liotta Lance   Kohn Elise C  

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 647-653

Future Medicine

Access to resources Recommend Favorite

Proteomic Classification of Breast Cancer

By  

Current Drug Targets, Vol. 13, Iss. 12, 2012-11 ,pp. : 1495-1509

Bentham Science Publishers

Access to resources Recommend Favorite

The use of accelerator mass spectrometry to obtain early human ADME/PK data

By Lappin Graham   Garner R Colin  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 2, 2007-04 ,pp. : 89-105

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Computer Software for the Interpretation and Management of Mass Spectrometry Data in Pharmaceutical Science

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-01 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite